MedNous | Business of medical innovation

Evernow Publishing Ltd Privacy Policy. Read more.

Free featured article

Nobel Prize for cancer research

Country

Sweden

Two scientists who identified proteins which act as a break on the immune system have been awarded the 2018 Nobel Prize in Physiology or Medicine for their discovery, which is the scientific basis for the ‘immune checkpoint’ class of medicines. James P. Allison, who discovered CTLA-4, and Tasuku Honjo, who discovered PD-1, were cited by the Nobel Assembly at Karolinska Institutet for their landmark work in the global fight against cancer.

New gene therapy platform

Country

United States

A new gene therapy company that uses chemogenetics-based technology has been launched in the US with plans to develop a product aimed at managing chronic neuropathic pain. CODA Biotherapeutics Inc is based in South San Francisco, California and made its debut on 12 September with a $19 million in Series A financing.

Themis Bioscience in oncolytic virus deal

Country

Austria

Austria-based Themis Bioscience GmbH has entered into a licencing agreement with Max-Planck-Innovation GmbH, the technology transfer arm of the Max Planck Society of Germany, for exclusive rights to an oncolytic measles virus platform that could be used to develop new oncology drugs.

The technology was jointly developed by Eberhard-Karls-University Tübingen and the Max Planck Institute for Biochemistry. Financial terms of the agreement were not disclosed.